why choose us

First received: February 01, 2023

Clinical Trial: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rotator Cuff Tendinopathy

Study Type: INTERVENTIONAL


Official Title: A Randomized, Parallel-group, 24 Week, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy and Safety of Secukinumab Compared to Placebo in Adult Patients With Active Ro

Brief Summary: The purpose of the present study is to assess the efficacy of secukinumab 300 mg s.c.(subcutaneous) compared to placebo, each in combination with standard of care, in improving signs, symptoms and physical function in participants with moderate to severe rotator cuff tendinopathy (RCT), using a randomized, double-blind, placebo controlled, parallel group design to minimize bias.

Read more